1Raskob EG, Silverstein R, Bratzler WD, et al. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med, 2010, 38(4 Suppl) : 502-509.
2Klatsky AL, Armstrong M, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in asian-americans. Am J Cardiol, 2000, 85: 1334-1337.
3Galanis T, Kraft WK, Merli GJ. Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient. Adv Surg,2011,45 :361-390.
5Cosmi B, Legnani C, Iorio A, et alone and in combination with al. Residual venous obstruction, D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. Eur J Vasc Endovasc Surg, 2010, 39: 356-365.
7Parikh S, Motarjeme A, Mcnamara T, et al. Uhrasound-accelerated thrombolysis for the treatment of deep vein thrombosis : initial clinical experience. J Vasc Interv Radiol, 2008, 19: 521- 528.
8Btiller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease:the Seventh ACCP Conference on Antithrombotic and Thrombolytie Therapy. Chest, 2004, 126 (3 Suppl) : 401S-428S.
9Ll , Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest ,2008,133 (6 Suppl) :454S-545S.
10Strijkers RH, Cate-Hoek AJ, Bukkems SF,et al. Management of deep vein thrombosis and prevention of post-thrombotic syndrome. BMJ,2011, 343 :d5916.
8Douma RA,Tan M,Schutgens R,et al.Using an age-dependent D-dimer cut-offvalue increases the number of older patients in whom deep vein thrombosis can be safely excluded[J].Haematologiea,2012;97( 10): 1507- 1513.
10Haas FJ,Schutgens RE,Biesma HD.An age-adapted approach for the use of D-dimers in the exclusion of deep venous thrombosis[J].Am J ttematol 2009 84(8):488-491.